CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2025	Sep. 30, 2024
CONDENSED BALANCE SHEETS
Cash and cash equivalents	$ 1,792,856	$ 4,738,173
Prepaid expenses	304,133	294,097
Supplies used for R&D and manufacturing	518,040	1,019,908
Deposit	7,500	3,500
Total current assets	2,622,529	6,055,678
Finance lease right-of-use assets	5,998,731	7,350,364
Operating lease right-of-use assets	1,332,096	1,495,937
Property and equipment, net	6,578,679	8,129,753
Patent costs, net	130,585	165,492
Deposits	2,319,101	2,319,101
Supplies used for R&D and manufacturing, Noncurrent	1,354,478	1,475,441
Total assets	20,336,199	26,991,766
Current Liabilities:
Accounts payable	1,577,215	1,448,467
Accrued expenses	475,602	566,042
Due to employees	1,169,520	363,306
Finance lease liabilities, current portion	2,205,972	2,010,995
Operating lease liabilities, current portion	187,739	226,969
Total current liabilities	5,616,048	4,615,779
Finance lease liabilities, net of current portion	6,271,813	7,957,925
Operating lease liabilities, net of current portion	1,298,398	1,425,979
Other liabilities	125,000	125,000
Total liabilities	13,311,259	14,124,683
STOCKHOLDERS' EQUITY
Preferred stock, $0.01 par value; 200,000 shares authorized; 0 shares issued and outstanding	0	0
Common stock, $0.01 par value; 600,000,000 shares authorized; 5,321,341 and 2,126,237 shares issued and outstanding at June 30, 2025 and September 30, 2024, respectively	53,214	21,266
Additional paid-in capital	540,293,742	526,857,678
Accumulated deficit	(533,322,016)	(514,011,861)
Total stockholders' equity	7,024,940	12,867,083
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 20,336,199	$ 26,991,766